WCG ClinSphere™总可行性发布自助功能以优化临床试验中心选择-动脉网

WCG ClinSphere™ Total Feasibility Releases Self-Serve Capabilities that Optimize Clinical Trial Site Selection

CISION 等信源发布 2025-03-27 21:00



可切换为仅中文







CARY, N.C.

凯里，北卡罗来纳州

，

March 27, 2025

2025年3月27日

/PRNewswire/ -- WCG, a global leader in providing solutions that measurably improve and accelerate clinical research, today announced the launch of WCG ClinSphere™ Total Feasibility's Software-as-a-Service (SaaS) technology solution, designed to address the most important clinical trial study start-up decisions for sponsors and contract research organizations (CROs).

/PRNewswire/ -- 全球领先的临床研究解决方案提供商WCG今日宣布推出WCG ClinSphere™ Total Feasibility的软件即服务（SaaS）技术解决方案，旨在帮助申办方和合同研究组织（CRO）解决临床试验启动阶段最重要的决策问题。

This innovative application streamlines communication and enables faster decision-making by providing centralized data access with standardized questions that allows sites to pre-populate questionnaires to reduce redundancy and enhance clinical trial success..

这一创新应用程序通过提供集中式数据访问和标准化问题，简化了沟通并加快了决策速度，允许站点预填充问卷以减少冗余并提高临床试验成功率。

WCG ClinSphere™ Total Feasibility doubles site feasibility response rates compared to the industry average and significantly reduces timelines and burdens for both sponsors and sites during the site evaluation and selection process. Users now have an option of self-service or high-touch experience with wrap-around services, providing clinical development insights and site identification for end-to-end study start-up support..

WCG ClinSphere™ Total Feasibility 将研究中心可行性响应率提高至行业平均水平的两倍，并在研究中心评估与选择过程中显著缩短时间线，减轻申办方和研究中心的负担。用户现在可选择自助服务或高接触体验的全方位服务，提供临床开发洞察和研究中心识别，为端到端的研究启动提供支持。

'On average, sites spend 200 hours per month completing feasibility activities, and up to 87% of questionnaires are considered redundant,' said

“平均而言，站点每月花费200小时完成可行性活动，且多达87%的问卷被认为多余，”

Cristin MacDonald

克里斯汀·麦克唐纳

, vice president, Client Delivery, WCG. 'Our solution automates and streamlines these processes, allowing research teams to focus on new and critical information, ultimately enhancing study success and accelerating timelines.'

WCG客户交付副总裁表示：“我们的解决方案自动化并简化了这些流程，使研究团队能够专注于新的和关键的信息，最终提高研究成功率并加快时间表。”

'WCG ClinSphere™ Total Feasibility revolutionizes the study start-up process,' said

“WCG ClinSphere™ Total Feasibility 革新了研究启动过程，”

Sam Srivastava

萨姆·斯里瓦斯塔瓦

, chief executive officer, WCG. 'By integrating comprehensive data combined with user-friendly tools, we empower research teams with the insights they need to make informed decisions quickly. This innovation is central to our mission to improve lives by accelerating research, bringing life-saving treatments to patients sooner.'.

WCG首席执行官表示：“通过整合综合数据并结合用户友好的工具，我们为研究团队提供所需的洞察力，以帮助他们快速做出明智的决策。这一创新是我们加速研究、尽快为患者带来挽救生命的治疗的核心使命。”

Key features of WCG ClinSphere™ Total Feasibility include:

WCG ClinSphere™ 总可行性关键特性包括：

Enhanced Investigator and Site Profiles:

增强的调查员和现场概况：

Utilizing the power of WCG's extensive data, surveys are pre-populated to reduce site workload and accelerate responses. With more than 300 standardized fields, users can access comprehensive details on site capabilities, staff, and logistics.

利用WCG庞大数据库的力量，预先填充调查数据以减少现场工作量并加快响应速度。通过300多个标准化字段，用户可以获取有关现场能力、员工和物流的详细信息。

Data-Driven Decision Support:

数据驱动的决策支持：

Leveraging information from proprietary, robust data, the application offers unique insights, streamlining the assessment process to find the best-fit investigators and sites for each study.

利用来自专有、强大数据的信息，该应用提供独特的见解，简化评估流程，为每项研究找到最合适的调查人员和地点。

Interactive Dashboards and Real-Time Tracking:

交互式仪表板和实时跟踪：

Sponsors have immediate access to progress and status updates through interactive dashboards. Real-time tracking, scoring, and response analysis enable rapid decision-making.

赞助商可以通过交互式仪表板即时获取进展和状态更新。实时跟踪、评分和响应分析能够实现快速决策。

Integrated Feasibility Solutions:

综合可行性解决方案：

WCG's Total Feasibility solution minimizes redundancy, speeds results, and improves collaboration, reducing the workload for sites and providing faster turnaround times.

WCG的全面可行性解决方案最大限度地减少了冗余，加快了结果速度并改善了协作，减轻了现场的工作负担并提供了更快的周转时间。

For sponsors and CROs, the new self-service capability offers a valuable tool to streamline operations, reduce costs, and improve relationships with sites during the feasibility process for their clinical trials. This launch represents a significant advancement in WCG's comprehensive suite of solutions designed to support the entire clinical trial lifecycle..

对于申办方和合同研究组织（CRO），新的自助功能提供了一个宝贵的工具，可以在其临床试验的可行性过程中简化操作、降低成本并改善与试验站点的关系。此次发布标志着WCG综合解决方案套件在支持整个临床试验生命周期方面取得了重要的进步。

For more information on WCG ClinSphere™ Total Feasibility, visit

有关 WCG ClinSphere™ Total Feasibility 的更多信息，请访问

https://www.wcgclinical.com/technologies/total-feasibility/

About WCG

关于WCG

WCG is a global leader of solutions that measurably improve and accelerate clinical research. Biopharmaceutical and medical device companies, contract research organizations (CROs), research institutions, and sites partner with us for our unmatched expertise, data intelligence, and purpose-built technology to make informed decisions and optimize study outcomes, while maintaining the highest standards of human participant protection.

WCG是全球领先的解决方案提供商，可显著改进和加速临床研究。生物制药和医疗器械公司、合同研究组织 (CRO)、研究机构和站点与我们合作，借助我们无与伦比的专业知识、数据智能和专为目标打造的技术，做出明智决策并优化研究结果，同时始终维持对人类参与者保护的最高标准。

WCG raises the bar by pioneering new concepts, reimagining processes, fostering compliance and safety, and empowering those who perform clinical trials to accelerate the delivery of medical therapies and devices that improve lives. For more information, please visit .

WCG通过开创全新理念、重新构想流程、促进合规与安全，以及赋能那些从事临床试验的人员，提高了行业标准，从而加速了改善生命的医疗疗法和设备的交付。欲了解更多信息，请访问。

wcgclinical.com

or follow us on

或关注我们

领英

or X

或 X

@WCGClinical

@WCG临床

。

SOURCE WCG

来源 WCG